Aneuploidy, referring here to genome contents characterized by abnormal numbers of chromosomes, has been associated with developmental defects, cancer and adaptive evolution in experimental organisms [1] [2] [3] [4] [5] [6] [7] [8] [9] . However, it remains unresolved how aneuploidy impacts gene expression and whether aneuploidy could directly bring about phenotypic variation and improved fitness over that of euploid counterparts. Here we show, using quantitative mass spectrometry-based proteomics and phenotypic profiling, that levels of protein expression in aneuploid yeast strains largely scale with chromosome copy numbers, following the same trend as that observed for the transcriptome, and that aneuploidy confers diverse phenotypes. We designed a novel scheme to generate, through random meiotic segregation, 38 stable and fully isogenic aneuploid yeast strains with distinct karyotypes and genome contents between 1N and 3N without involving any genetic selection. Through quantitative growth assays under various conditions or in the presence of a panel of chemotherapeutic or antifungal drugs, we found that some aneuploid strains grew significantly better than euploid control strains under conditions suboptimal for the latter. These results provide strong evidence that aneuploidy directly affects gene expression at both the transcriptome and proteome levels and can generate significant phenotypic variation that could bring about fitness gains under diverse conditions. Our findings suggest that the fitness ranking between euploid and aneuploid cells is dependent on context and karyotype, providing the basis for the notion that aneuploidy can directly underlie phenotypic evolution and cellular adaptation.
Whole-chromosome or segmental aneuploidy has been observed in a wide range of organisms and conditions, from pathogenic and experimental fungal species adapting to growth inhibition, to human diseases such as cancer and Down's syndrome [2] [3] [4] [5] [6] [7] [8] [9] [10] , but it is still not known how aneuploidy affects gene expression and cellular physiology 1, [11] [12] [13] . The budding yeast Saccharomyces cerevisiae, with its 16-chromosome complement, has been a useful experimental model for addressing this question at a fundamental level. Experimental evolution in yeast suggested a correlation between the emergence of aneuploidy and adaptive phenotypes in response to various perturbations [3] [4] [5] [6] [7] 10 . Transcriptome profiling demonstrated that aneuploidy causes changes in messenger RNA levels that mostly scale with chromosome copy numbers, and well beyond for some genes 7, 10, 11 . In contrast, two recent studies concluded that aneuploidy decreases cellular fitness irrespective of the specific karyotype 11, 12 and suggested that dosage compensation for proteins encoded on aneuploid chromosomes correlates with a common stress response, dubbed 'proteotoxic stress' 11 . This raises the following conundrum: if net protein expression levels are insensitive to chromosome stoichiometry, and aneuploidy inevitably impairs fitness, how might aneuploidy provide phenotypic variation and possibly fitness advantages under selective conditions? 13 We sought to resolve this conundrum by using a panel of aneuploid yeast strains with a wide range of karyotypes grown under diverse conditions. In particular, our experiments were designed to answer the following questions. First, can aneuploidy directly confer phenotypic variation and possibly improved fitness? And second, is the proteome proportionally affected by chromosome copy-number variation due to aneuploidy?
To generate fully isogenic and stable aneuploid strains, containing a wide range of chromosome stoichiometries and without the need for any genetic selection, we induced meiosis in yeast strains with an odd ploidy (3N or 5N), which produces aneuploid progenies at high frequencies 14, 15 ( Fig. 1a ). To minimize other genetic variation, we generated the starting triploid and pentaploid progenitor strains by cycles of mating type switching and mating, from a single haploid S288c strain (Supplementary Fig. 1a ). Absence of segmental chromosome abnormalities in the resulting polyploid progenitors was verified by array-based comparative genomic hybridization (aCGH), although the pentaploid strain had quickly lost one copy of chromosomes III and V ( Supplementary  Fig. 1b ). To isolate aneuploid strains with stable karyotypes, we used a multistep approach (detailed in Supplementary Methods). In brief, each spore was first spread on a yeast extract peptone dextrose plate to form single colonies ( Fig. 1a ). From each resulting plate with uniform colony sizes 11 colonies were picked randomly and analysed by fluorescence-activated cell sorting (FACS) to identify those original spores producing colonies with uniform ploidy ( Supplementary Fig.  2a , b). Karyotype stability was further verified after freezing and revival ( Supplementary Fig. 2c ). The karyotypes of the final aneuploid strains were determined by a new quantitative polymerase chain reaction (qPCR)-based assay that allows accurate karyotyping in high-throughput formats ( Fig. 1b-f , Supplementary Methods and Supplementary Fig. 2d ). A subset of the karyotypes was also confirmed by aCGH ( Fig. 1b-f and Supplementary Fig. 3 ). To minimize the accumulation of single-nucleotide mutations, all aneuploid strains were passaged no more than three times between initial derivation and experimental use. Indeed, whole-genome resequencing of the five aneuploid strains used for the transcriptome and proteome analyses (see below) revealed an absence of mutations in coding regions that were not already present in the parental strains (Supplementary Information). The above procedure yielded 38 isogenic stable aneuploid strains (12.5% of spores analysed) with a ploidy between 1N and 3N, harbouring 35 distinct karyotypes, mostly with multiple chromosomes in aneuploidy ( Supplementary Fig. 4 ). Except for chromosomes II and IX, all 16 yeast chromosomes were equally represented as aneuploid chromosomes in this collection (Fig. 1g ). The chromosome number distributions were skewed towards the left (lower number) from those expected from random meiosis I segregation ( Fig. 1h ), suggesting that strains with larger numbers of aneuploid chromosomes are either less viable or karyotypically unstable.
Growth comparison of the aneuploid strains with isogenic 1N, 2N and 3N euploid strains in rich medium at 23 uC confirmed the previous observation that most aneuploid strains grew poorly in comparison with euploid controls 11 , although a few aneuploid strains grew similarly to the euploids ( Fig. 2a-c ). Next we compared the growth under conditions divergent from that optimal for euploid yeast cells, including environmental perturbations, such as extreme temperature or pH or nutrient shortage, and the presence of chemotherapeutic or antifungal drugs ( Supplementary Table 2 ). Strikingly, although under every condition most aneuploid strains grew more slowly than or as poorly as the euploids, under several conditions, especially those severely retarding euploid growth, some aneuploid strains showed improved growth in comparison with euploids ( Fig. 2e-h and Supplementary Fig. 5 ). Karyotyping at the end of the growth assays confirmed persistent karyotype stability in most cases (Supplementary Information). For example, several aneuploid strains grew significantly better than euploid strains in rich medium at 16 uC ( Fig. 2e , f) or in the presence of drugs such as rapamycin (an immunosuppressant and proposed anticancer agent), bleomycin (a chemotherapeutic compound), thiolutin (an antibiotic) or fluconazole (an antifungal drug) at concentrations inhibitory to euploid growth ( Fig. 2g , h, Supplementary Fig. 5 and Supplementary Table 3 ). The observed phenotypic diversity was unlikely to have been due to differences in mating type, because euploid strains with different mating types grew similarly under the tested conditions (Supplementary Fig. 6 ).
To understand how phenotypes relate to karyotypes, we clustered the aneuploid strains on the basis of karyotypic similarity ( Fig. 2i ) and clustered the conditions used in the phenotypic profiling on the basis of their effects on growth ( Fig. 2j and Supplementary Methods). This analysis revealed that, first, several pairs of aneuploid strains with identical karyotypes (for example A26 and A27; A31 and A33) or similar karyotypes (for example A8 and A17; A1 and A16; A20 and A21) showed similar growth patterns across the different conditions. I II  II I  IV V  V I  V II  V II I  IX X  X I  X II  X II I  X IV  X V  X V I   I  II  II I  IV V  V I  V II  V II I  IX  X  X I  X II  X II I  X IV   X V  X V I  I II  II I  IV  V  V I  V II  V II I  IX  X  X I  X II  X II I  X IV   X V  X V I   I II  II I  IV V  V I  V II  V II I  IX X X I X II  X II I 
RESEARCH LETTER
Second, along each growth condition (column in Fig. 2j ), divergent karyotypes can often be observed that showed improved growth compared with the haploid control. To pinpoint a specific mechanism linking a specific aneuploid karyotype to a specific fitness improvement, we noticed that strain A16, resistant to 4-nitroquinoline-Noxide (4-NQO, a tumorigenic compound), had only chromosome XIII in aneuploidy. Chromosome XIII harbours the gene ATR1, encoding a transporter protein known to confer 4-NQO hyper-resistance when overexpressed 16 . We confirmed that an extra copy of chromosome XIII in strain A16 led to a proportional increase in mRNA expression of ATR1 in both the presence and absence of 4-NQO ( Supplementary  Fig. 7a ). Deletion of the extra copy of ATR1 from the 4-NQO-resistant aneuploid strains restored the expression of ATR1 to levels comparable to those of the euploid (Supplementary Fig. 7a ) and abolished their resistance to 4-NQO ( Fig. 2d and Supplementary Fig. 7b, c) , demonstrating that the increased ATR1 copy number was required for 4-NQO resistance. Furthermore, introducing one extra copy of the ATR1 gene expressed under its own promoter into haploid or diploid euploid strains was sufficient to confer resistance to 4-NQO ( Fig. 2d and Supplementary Fig. 7b, c) .
Immunoblot analysis of disomic yeast strains suggested that most proteins encoded on aneuploid chromosomes may be dosage compensated 11 , raising a question as to how aneuploidy might confer large phenotypic variation, as observed above. To investigate this further, we performed parallel RNA microarray and quantitative proteomics analysis on five aneuploid strains of the same mating type but with A10  A15  A13  A2  A3  A5  A4  A18  A35  A38  A32  A34  A28  A19  A23  A6  A7  A30  A22  A12  A29  A36  A9  A11  A14  A26  A27  A1  A16  U2  U1  U3  A37  A31  A33  A25  A24  A20  A21   I II  II I IV  V  V I  V II  IX  X  X I  X II  X II I  X A17  A8  A10  A15  A13  A2  A3  A5  A4  A18  A35  A38  A32  A34  A28  A19  A23  A6  A7  A30  A22  A12  A29  A36  A9  A11  A14  A26  A27  A1  A16  U2  U1  U3  A37  A31  A33  A25  A24  A20  A21   V II I   U1  A16 U1, 1× ATR1 U1, 1× ATR1 DMSO U1   U1   U2   U2   U3   U3   A1   A2   A3   A5   A4   A6   A7   A8   A9   A10   A11   A12   A13   A14   A15   A16   A17  A38   A35   A24   A32   A25   A27   A29   A28   A30   A26   A31   A32   A19   A23   A18   A34   A36   A22   A20   A21   A37   P2   P1   P3  P4   2  4  1  3  6  8  5  7  10  12  9 1 1 LETTER RESEARCH different growth rates and chromosome stoichiometries. MudPIT (multidimensional protein identification technology) analysis 17 on the soluble fraction of whole-cell extracts identified about 2,000 different gene products per strain, representing about 33% of the yeast proteome, with highly reproducible quantification of protein abundances across the biological replicates and broad coverage of all cellular components ( Supplementary Fig. 8 and Supplementary Table 4 ). This analysis revealed that strains with similar karyotypes tend to have similar global proteomic changes ( Supplementary Fig. 8a ) and that changes in chromosome copy numbers resulting from aneuploidy lead to proportional changes in the chromosomal average protein expression, following the same trend as the transcriptome (Fig. 3a-c and Supplementary Figs 9 and 10a) , indicating a direct gene dosage effect on the proteome. Dosage compensation was also minimal and in most cases insignificant for core complex proteins 18 encoded on aneuploid chromosomes ( Supplementary Fig. 10b ). The mRNA and protein levels of individual genes were modestly, although significantly, correlated even after correcting for chromosomal copy number effect ( Fig. 3d and Supplementary Fig. 11 ), which is consistent with a recent proteomic analysis of haploid versus diploid yeast 19 . However, among the genes with expression changes two standard deviations away from their chromosomal average (referred to as 'outlier' genes), only a fraction (about 3-14%) were common between the microarray and the proteomics data sets ( Fig. 3d and Supplementary  Fig. 11 ). As a result, mRNA outliers and protein outliers were enriched for distinct classes of biological processes, and no specific class of genes was consistently found to be significantly enriched across all aneuploid strains (Fig. 3e, f and Supplementary Fig. 12a, b ), suggesting a lack of a common gene expression response to aneuploidy. Because genes of the 'response to stress' category were not enriched in either the transcriptome or the proteome in any of our aneuploid strains, in contrast with the conclusion of the previous study 11 , we further performed a more stringent analysis by considering only outlier genes expressed more than three standard deviations from the chromosomal average in our microarray data. Enrichment for either 'response to stress' (Gene Ontology) or 'environmental stress response' genes 20 was found in three of the five aneuploid strains, but this enrichment was not correlated with either growth rates or the number of aneuploid chromosomes ( Supplementary Fig. 12c ). Taken together, the above results indicate that aneuploidy has global and complex effects at both the transcriptome and proteome levels, and that an increase in stress gene expression is not a obligate property of aneuploid strains. Fig. 1b-f ), average mRNA level (b, microarray data; normalized mRNA log 2 ratio (aneuploid/euploid)) and average protein level (c, proteomics data; normalized protein log 2 ratio (aneuploid/euploid); see Supplementary Fig. 9 ) per chromosome of the five aneuploid strains compared with U1. d, Correlation between protein expression and gene expression changes in strain A2 relative to haploid euploid strain U1 (for other strains, see Supplementary Fig. 11 ). Outlier mRNAs and proteins (defined as in Supplementary Information) are highlighted in red and blue, respectively. e, f, Subset of GO-Slim (a cut-down version of gene ontologies containing a subset of the GO terms) analysis applied to outlier genes from microarray (e) and proteomics (f) data sets (see Supplementary Methods for details).
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Complete results are given in Supplementary Fig. 12a, b . P values were calculated from hypergeometric tests.
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Our analysis of a large set of isogenic and stable aneuploid yeast strains with broad chromosome stoichiometries demonstrates that aneuploidy directly confers phenotypic variation and sometimes growth advantage under conditions that are suboptimal for euploid cells. These observations suggest that aneuploidy does not inevitably result in growth impairment, but rather that the impact of aneuploidy on cellular fitness depends on both karyotype and conditions. The difference between our findings and the previous observation of a common stress signature and proliferative disadvantage across disomic yeast strains 11 may be that in our study the naturally stable, multiplechromosome aneuploidy resulted in fewer protein expression imbalances than single-chromosome aneuploidy maintained through continuous selection with drugs and nutrient markers. Furthermore, our proteomic analysis, performed in quadruplicate and quantifying thousands of proteins encoded on aneuploid chromosomes, in contrast with just 16 proteins analysed by immunoblotting in the previous work, revealed a wholesale chromosome dosage effect on the proteome, consistent with a recent report of effects of gene copy number on protein levels 21 . These findings suggest that aneuploidy is a large-effect mutation profoundly altering gene expression at the functional level. Under conditions that euploid cells are well adapted to, the large phenotypic effects caused by aneuploidy are likely to cause a decrease in fitness that could lead to the rapid clearance of most aneuploid cells from the population. However, under a strong selective pressure due to adverse environmental changes or clinical drug treatments, the rise of aneuploidy, readily achieved through erroneous mitosis, can be a highly effective mechanism to generate phenotypic variation and rapid adaptation.
METHODS SUMMARY
Generation of a collection of isogenic aneuploid yeast strains. Homozygous triploid and pentaploid strains were generated as described in Supplementary Fig. 1a . Aneuploid strains were generated by sporulation of the above polyploid strains, followed by karyotype stability tests and determination as described in Fig. 1a and Supplementary Fig. 2 . Strains and plasmid are listed in Supplementary Information. Karyotyping. aCGH, performed as described previously 7 , and qPCR were used for karyotyping. qPCR assays were designed with primers in non-coding regions on each chromosome arm (primer sequences are listed in Supplementary Table 1 ). DNA samples were prepared by alkaline lysis, and qPCR reactions were performed in 384-well plates with a BioMek FX (Beckman Coulter) to assemble 10-ml reactions and an ABI 7900HT (Applied Biosystems) for cycling. Chromosome copy numbers were determined with a modified DDC t method (Supplementary Methods). Phenotypic profiling. Equal amounts (D 600 ) of aneuploid and euploid control cultures were spotted, with the Biomek FX robot, onto OmniTrays containing various solid media and grown under conditions listed in Supplementary Table 2 . OmniTrays representing three biological replicates of each tested condition were scanned on a Hewlett-Packard ScanJet 4070 desktop scanner. Growth data were obtained by automated spot detection and intensity measurements. Quantitative whole-genome proteomics. Whole-cell lysates were prepared from 50 ml of cycling yeast cultures by bead-beating. High-speed supernatants were collected and precipitated. Chromatography and mass spectrometry analysis were performed as described previously 22 . The tandem mass spectrometry data sets were searched using SEQUEST 23 against a database of 11,986 sequences, consisting of 5,816 S. cerevisiae non-redundant proteins (NCBI), 177 contaminants and 5,993 decoy sequences. Relative protein levels were determined by calculating distributed normalized spectral abundance factors 24 . Statistical analysis. All statistical analyses were performed in the R environment 25 using standard packages and custom scripts.
